Shucai Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shucai Yang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Kai Li
Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China
1 shared publication - Lei Zhang
Department of Pathology, Harbin Medical University, Harbin, China
1 shared publication - Li Zhao
Department of Oncology I, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publication Minjie Wei
School of Pharmacy, China Medical University, Shenyang, China
1 shared publicationRuo Zhang
Shuwen Biotech Co. Ltd., Deqing, China
1 shared publication- Xinxin Feng
College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China
1 shared publication
Latest Publications
- Open Access
- 6 May 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-8
TROAP Promotes Breast Cancer Proliferation and Metastasis
Trophinin-associated protein (TROAP) is a cytoplasmic protein required for microtubular cytoskeleton regulation and spindle assembly, and its expression plays a critical role in the initiation and progression of various types of cancer. However, little is known about the role of TROAP in breast cancer (BC). TROAP mRNA expression levels and clinical data from Gene Expression Omnibus (GEO) datasets (GSE42568, 104 BC patients; GSE1456, 159 BC patients; and GSE21653, 266 BC patients) were analyzed by the R2: Genomics Analysis and Visualization Platform to estimate overall survival (OS). We also analyzed the genes correlated with TROAP by gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis to predict potential relationships between TROAP and other genes in BC. Our study verified that both TROAP mRNA and protein expression levels were upregulated in human BC samples and cell lines. In vitro experiments demonstrated that TROAP knockdown significantly inhibited cell proliferation, the G1 to S phase transition, and the migration and invasion abilities of BC cells. The present study suggests that TROAP plays an important role in promoting the proliferation, invasion, and metastasis of BC.
- 6 May 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-8
Open AccessTROAP Promotes Breast Cancer Proliferation and Metastasis
Trophinin-associated protein (TROAP) is a cytoplasmic protein required for microtubular cytoskeleton regulation and spindle assembly, and its expression plays a critical role in the initiation and progression of various types of cancer. However, little is known about the role of TROAP in breast cancer (BC). TROAP mRNA expression levels and clinical data from Gene Expression Omnibus (GEO) datasets (GSE42568, 104 BC patients; GSE1456, 159 BC patients; and GSE21653, 266 BC patients) were analyzed by the R2: Genomics Analysis and Visualization Platform to estimate overall survival (OS). We also analyzed the genes correlated with TROAP by gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis to predict potential relationships between TROAP and other genes in BC. Our study verified that both TROAP mRNA and protein expression levels were upregulated in human BC samples and cell lines. In vitro experiments demonstrated that TROAP knockdown significantly inhibited cell proliferation, the G1 to S phase transition, and the migration and invasion abilities of BC cells. The present study suggests that TROAP plays an important role in promoting the proliferation, invasion, and metastasis of BC.